Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does combined clopidogrel and statin therapy benefit patients with non-ST-elevation myocardial infarction?

Nature Clinical Practice Cardiovascular Medicine volume 2, pages 558–559 (2005)Cite this article

boxed-textLim MJ et al. (2005) Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry. Eur Heart J 26: 1063–1069

Statins do not have an antagonistic effect on the antiplatelet effect of clopidogrel but aspirin is still the antiplatelet agent of choice for ACS patients

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Gluckman TJ et al. (2005) A simplified approach to the management of non-ST-segment elevation acute coronary syndromes. JAMA 293: 349–357

    Article  CAS  Google Scholar 

  2. Stephen Monroe V et al. (2003) Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndromes. J Am Coll Cardiol 40 (Suppl 1): S23–S30

    Article  Google Scholar 

  3. Altman R et al. (2004) The antithrombotic profile of aspirin. Aspirin resistance, or simply failure? Thromb J 2: 1

    Article  Google Scholar 

  4. Hirsh J and Bhatt DL (2004) Comparative benefits of clopidogrel and aspirin in high-risk patient populations: lessons from the CAPRIE and CURE studies. Arch Intern Med 164: 2106–2211

    Article  CAS  Google Scholar 

  5. Hippisley-Cox J and Coupland C (2005) Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis. BMJ 330: 1059–1063

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Associate Editor Nature Clinical Practice.

Author information

Authors and Affiliations

  1. a Professor and Director of the Masters Course in Thrombosis at the Faculty of Medicine, National University of Tucumán, Argentina

    Raul Altman

Authors
  1. Raul Altman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raul Altman.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Altman, R. Does combined clopidogrel and statin therapy benefit patients with non-ST-elevation myocardial infarction?. Nat Rev Cardiol 2, 558–559 (2005). https://doi.org/10.1038/ncpcardio0339

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0339

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing